TriSalus Life Sciences (TLSI) Selling, General & Administrative (2021 - 2026)
TriSalus Life Sciences (TLSI) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.69 Bn | 175.40 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 108.07 Bn | 98.85 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 67.93 Bn | 66.47 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 48.11 Bn | 44.44 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 349.70 Mn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.60 Bn | 1.98 Bn | 1.12 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.05 Bn | 20.92 Bn | 2.07 Bn | -207.22 Mn |
| 10 | TriSalus Life Sciences | 222.65 Mn | 166.10 Mn | 7.67 Mn | 5.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.45 Mn |
| Dec 31, 2025 | 4.17 Mn |
| Sep 30, 2025 | 6.66 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Mar 31, 2025 | 5.25 Mn |
| Dec 31, 2024 | 4.66 Mn |
| Sep 30, 2024 | 4.73 Mn |
| Jun 30, 2024 | 3.96 Mn |
| Mar 31, 2024 | 4.63 Mn |
| Dec 31, 2023 | 6.01 Mn |
| Sep 30, 2023 | 9.03 Mn |
| Jun 30, 2023 | 4.90 Mn |
| Mar 31, 2023 | 3.55 Mn |
| Dec 31, 2022 | 4.06 Mn |
| Sep 30, 2022 | 3.50 Mn |
| Jun 30, 2022 | 288,273.00 |
| Mar 31, 2022 | 669,807.00 |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 807,259.00 |
| Jun 30, 2021 | 783,925.00 |